[1] ROSS R.Atherosclerosis--an inflammatory disease[J].N Engl J Med,1999,340(2):115-126.
[2] DIEHL AG,BOYLE AP.Deciphering ENCODE[J].Trends Genet,2016,32(4):238-249.
[3] KHYZHA N,ALIZADA A,WILSON MD,et al.Epigenetics of atherosclerosis:emerging mechanisms and methods[J].Trends Mol Med,2017,23(4):332-347.
[4] FEINBERG MW,MOORE KJ.MicroRNA regulation of atherosclerosis[J].Circ Res,2016,118(4):703-720.
[5] TADIN-STRAPPS M,PETERSON LB,CUMISKEY AM,et al.SiRNA-induced liver apoB knockdown lowers serum LDL-cholesterol in a mouse modelwith human-like serum lipids[J].J Lipid Res,2011,52(6):1084-1097.
[6] JIAN L,JIAN D,CHEN Q,et al.Long noncoding RNAs in atherosclerosis[J].J AtherosclerThromb,2016,23(4):376-384.
[7] HOLDT LM,STAHRINGER A,SASS K,et al.Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans[J].Nat Commun,2016,7:12429.
[8] AMBROS V.The functions of animal microRNAs[J].Nature,2004,431(7006):350-355.
[9] BARTEL DP.MicroRNAs:target recognition and regulatory functions[J].Cell,2009,136(2):215-233.
[10] GUO H,INGOLIA NT,WEISSMAN JS,et al.Mammalian microRNAs predominantly act to decrease target mRNA levels[J].Nature,2010,466(7308):835-840.
[11] FRIEDMAN RC,FARH KK,BURGE CB,et al.Most mammalian mRNAs are conserved targets of microRNAs[J].Genome Res,2009,19(1):92-105.
[12] ROOIJ EVAN,PURCELL AL,LEVIN AA.Developing microRNA therapeutics[J].Circ Res,2012,110(3):496-507.
[13] GOEDEKE L,WAGSCHAL A,FERNANDEZ-HERNANDO C,et al.MiRNA regulation of LDL-cholesterol metabolism[J].Biochim Biophys Acta,2016,1861(12 Pt B):2047-2052.
[14] GOEDEKE L,ROTLLAN N,CANFRAN-DUQUE A,et al.MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels[J].Nat Med,2015,21(11):1280-1289.
[15] JIANG H,ZHANG J,Du Y,et al.MicroRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator[J].Atherosclerosis,2015,243(2):523-532.
[16] COHEN JC,BOERWINKLE E,MOSLEY TJ,et al.Sequence variations in PCSK9,low LDL,and protection against coronary heart disease[J].N Engl J Med,2006,354(12):1264-1272.
[17] ZAMBRANO T,HIRATA MH,CERDA A,et al.Impact of 3'UTR genetic variants in PCSK9 and LDLR genes on plasma lipid traits and response to atorvastatin in Brazilian subjects:a pilot study[J].Int J Clin Exp Med,2015,8(4):5978-5988.
[18] ALVAREZ ML,KHOSROHEIDARI M,EDDY E,et al.MicroRNA-27a decreases the level and efficiency of the LDL receptor and contributes to the dysregulation of cholesterol homeostasis[J].Atherosclerosis,2015,242(2):595-604.
[19] XU Y,ZALZALA M,XU J,et al.A metabolic stress-inducible miR-34a-HNF4alpha pathway regulates lipid and lipoprotein metabolism[J].Nat Commun,2015,6:7466.
[20] SOH J,IQBAL J,QUEIROZ J,et al.MicroRNA-30c reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion[J].Nat Med,2013,19(7):892-900.
[21] ESAU C,DAVIS S,MURRAY SF,et al.MiR-122 regulation of lipid metabolism revealed by in vivo antisense targeting[J].Cell Metab,2006,3(2):87-98.
[22] PETERSEN CP,BORDELEAU ME,PELLETIER J,et al.Short RNAs repress translation after initiation in mammalian cells[J].Mol Cell,2006,21(4):533-542.
[23] FITZGERALD K,WHITE S,BORODOVSKY A,et al.A highly durable RNAi therapeutic inhibitor of PCSK9[J].N Engl J Med,2017,376(1):41-51.
[24] RAY KK,LANDMESSER U,LEITER LA,et al.Inclisiran in patients at high cardiovascular risk with elevated LDL cholesterol[J].N Engl J Med,2017,376(15):1430-1440.
[25] RAMACHANDRAN PV,IGNACIMUTHU S.RNA interference--a silent but an efficient therapeutic tool[J].Appl Biochem Biotechnol,2013,169(6):1774-1789.
[26] WANG KC,CHANG HY.Molecular mechanisms of long noncoding RNAs[J].Mol Cell,2011,43(6):904-914.
[27] KORNFELD JW,BRUNING JC.Regulation of metabolism by long,non-coding RNAs[J].Front Genet,2014,5:57.
[28] UCHIDA S,DIMMELER S.Long noncoding RNAs in cardiovascular diseases[J].Circ Res,2015,116(4):737-750.
[29] ISHII N,OZAKI K,SATO H,et al.Identification of a novel non-coding RNA,MIAT,that confers risk of myocardial infarction[J].J Hum Genet,2006,51(12):1087-1099.
[30] KUMARSWAMY R,BAUTERS C,VOLKMANN I,et al.Circulating long noncoding RNA,LIPCAR,predicts survival in patients with heart failure[J].Circ Res,2014,114(10):1569-1575.
[31] VAUSORT M,WAGNER DR,DEVAUX Y.Long noncoding RNAs in patients with acute myocardial infarction[J].Circ Res,2014,115(7):668-677.
[32] LI P,RUAN X,YANG L,et al.A liver-enriched long non-coding RNA,lncLSTR,regulates systemic lipid metabolism in mice[J].Cell Metab,2015,21(3):455-467.
[33] HALLEY P,KADAKKUZHA BM,FAGHIHI MA,et al.Regulation of the apolipoprotein gene cluster by a long noncoding RNA[J].Cell Rep,2014,6(1):222-230.
[34] HU YW,YANG JY,MA X,et al.A lincRNA-DYNLRB2-2/GPR119/GLP-1R/ABCA1-dependent signal transduction pathway is essential for the regulation of cholesterol homeostasis[J].J Lipid Res,2014,55(4):681-697.
[35] SALLAM T,JONES MC,GILLILAND T,et al.Feedback modulation of cholesterol metabolism by the lipid-responsive non-coding RNA LeXis[J].Nature,2016,534(7605):124-128.
[36] TONTONOZ P,WU X,JONESM,et al.Long noncoding RNA facilitated gene therapy reduces atherosclerosis in a murine model of familial hypercholesterolemia[J].Circulation,2017,136(8):776-778.
[37] ZHANG Z,SALISBURY D,SALLAM T.Long non-coding RNAs in atherosclerosis:JACC review topic of the week[J].J Am Coll Cardiol,2018,72(19):2380-2390.
[38] HANSEN TB,VENO MT,DAMGAARD CK,et al.Comparison of circular RNA prediction tools[J].Nucleic Acids Res,2016,44(6):e58.
[39] ABDELMOHSEN K,PANDA AC,MUNK R,et al.Identification of HuR target circular RNAs uncovers suppression of PABPN1 translation by CircPABPN1[J].RNA Biol,2017,14(3):361-369.
[40] JAKOBI T,CZAJA-HASSE LF,REINHARDT R,et al.Profiling and validation of thecircular RNA repertoire in adult murine hearts[J].Genomics Proteomics Bioinformatics,2016,14(4):216-223.
[41] ZOU M,HUANG C,LI X,et al.Circular RNA expression profile and potential function of hsa_circRNA_101238 in human thoracic aortic dissection[J].Oncotarget,2017,8(47):81825-81837.
[42] SALGADO-SOMOZA A,ZHANG L,VAUSORT M,et al.The circular RNA MICRA for risk stratification after myocardial infarction[J].Int J Cardiol Heart Vasc,2017,17:33-36.
[43] VAUSORT M,SALGADO-SOMOZA A,ZHANG L,et al.Myocardial infarction-associated circular RNA predicting left ventricular dysfunction[J].J Am Coll Cardiol,2016,68(11):1247-1248.
[44] GENG HH,LI R,SU YM,et al.The circular RNA CDR1as promotes myocardial infarction by mediating the regulation of miR-7a on its target genes expression[J].PLoS One,2016,11(3):e151753.
[45] ZHAO Z,LI X,GAO C,et al.Peripheral blood circular RNA hsa_circ_0124644 can be used as a diagnostic biomarker of coronary artery disease[J].Sci Rep,2017,7:39918.